Hutch News

Hutch News

Stories tagged 'VIDD Research Interests'

Infections in immune-compromised patients: 5 new frontiers

Infectious disease experts gather in Seattle to find solutions for patients with compromised immunity

June 17, 2019 | By Sabin Russell / Fred Hutch News Service

Cancer and infectious disease researchers in Seattle last week focused on one of the most complex challenges in medical science: stopping infections in patients whose immune system are compromised.

View story >


Breaking down HIV exclusions in cancer clinical trials

As an eligibility barrier cracks, a lung cancer patient gets a new lease on life

June 7, 2019 | By Fred Hutch News Service staff

A new study led by physicians at Fred Hutchinson Cancer Research Center shows that patients with HIV and one of a variety of potentially deadly cancers can be safely treated with the immunotherapy drug pembrolizumab, also known by its brand name, KEYTRUDA®.

View story >


Engineering vaccine-like protection without a vaccine

CRISPR gene-editing used on antibody-making B cells

May 17, 2019 | By Sabin Russell / Fred Hutch News Service

A Hutch team led by Dr. Justin Taylor shows that B cells, which are crucial components of the immune system, can be genetically engineered to make exactly the antibodies we want. It could lead to a potentially more precise and dependable way to generate protection without vaccines.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.